Travel & financial grants

PAN Foundation

The PAN: Pemphigus Vulgaris (Medicare) program offers financial assistance to Medicare-insured patients for medication costs related to Pemphigus Vulgaris. It is a needs-based grant providing an annual maximum benefit of $7300, and applications are open. This grant does not appear to cover travel expenses.

PAN Foundation

This grant, provided by the PAN Foundation, offers financial assistance primarily for copay expenses for patients with pancreatic cancer. Additionally, grants from the PAN Foundation can cover transportation purchases. Applicants must undergo income verification to determine their eligibility.

PAN Foundation

The PAN Foundation offers financial assistance to patients with Parkinson's disease. While primarily for copay, the foundation also provides transportation grants and covers transportation purchases. Applicants must verify their income or insurance premium to determine eligibility.

Novartis Oncology

The Patient Assistance NOW (PANO) program, sponsored by Novartis Oncology, offers a co-pay assistance discount card for commercially insured patients taking Tasigna, and provides general patient assistance for uninsured patients requiring Gleevec or Tasigna. The National CML Society offers help with the application process for this program.

PEHP

The PEHP Pharmacy Tourism Program helps eligible PEHP members save money by filling specific prescription medications in Canada or Mexico. It covers roundtrip airfare for the member and a companion, one night hotel stay, and transportation to the designated foreign pharmacy. To qualify, members must be enrolled in a Traditional or STAR HSA plan, not be enrolled in Medicare, and not be affiliated with Jordan School District, Park City School District, or USBA.

PEHP

The PEHP Pharmacy Tourism Program assists eligible PEHP members (not enrolled in Medicare, excluding specific districts) by covering travel expenses to fill certain prescription medications in Canada or Mexico. It provides roundtrip airfare, local transportation to the pharmacy, a one-night hotel stay for the patient and a companion, and up to $750 cash back per trip. Eligibility is determined by PEHP after members contact their pharmacy services.

Genentech

Perjeta Access Solutions helps patients understand their insurance coverage and access financial assistance for Genentech's Perjeta medicine. The provided content does not indicate that this program offers assistance for travel expenses.

Pfizer

Pfizer

Pfizer

The Pfizer enCompass Co-Pay Assistance Program for ABRILADA helps eligible privately insured patients reduce their out-of-pocket costs for ABRILADA treatment to as little as $0. The program provides a maximum annual benefit ranging from $4,000 to $14,000 for co-pays or coinsurances. Patients are ineligible if they have state or federally funded insurance, are cash-paying, or are prescribed ABRILADA for adolescent HS, pediatric uveitis, or pediatric ulcerative colitis.

Pfizer

The Pfizer Gaucher Personal Support (GPS) program provides financial and insurance assistance for patients prescribed ELELYSO for Type 1 Gaucher disease. It offers a co-pay program for commercially insured patients (up to $15,000 annually) and a patient assistance program for uninsured or government-insured patients who meet financial qualifications. GPS also offers infusion support, including help researching transportation options to and from infusion sites.

Pfizer

The provided page describes various financial assistance programs from Pfizer Oncology Together primarily for covering the cost of Pfizer Oncology medicines, including co-pay assistance and reimbursement services for commercially insured patients. It also mentions a general patient assistance program. However, the page does not provide any information or details about a patient travel assistance grant.

Pfizer

The Pfizer Oncology Together Financial Assistance program, as described on this page, primarily offers co-pay assistance for Pfizer Oncology medicines, helping eligible commercially insured patients cover their deductible, co-pay, or coinsurance costs. Annual savings limits range from $6,000-$10,000 for oral medicines and $4,000-$25,000 for certain injectable medicines. The page does not mention assistance for travel expenses, though it notes no income requirements for some co-pay programs.

Pfizer

The Pfizer Oncology Together program provides financial assistance to commercially insured patients for their prescribed Pfizer Oncology medicines. This co-pay savings program helps cover out-of-pocket costs like deductibles, co-pays, or coinsurance. Eligible patients can receive up to $10,000 annually for oral medicines, and between $4,000-$25,000 annually for certain injectable medicines, with no income requirements for the latter.

Pfizer

Pfizer Oncology Together

This page for Pfizer Oncology Together Financial Assistance details various co-pay and financial assistance programs designed to help eligible patients cover the cost of their prescribed Pfizer Oncology medicines. It provides information on co-pay assistance for oral and injectable medications, as well as general financial support options. However, there is no information provided on this page regarding travel assistance for patients.

Pfizer

Pfizer

The Pfizer Oncology Together program provides financial assistance for out-of-pocket costs of prescribed Pfizer Oncology medicines. It offers co-pay assistance for eligible, commercially insured patients, potentially reducing monthly costs to as little as $0, with annual savings caps ranging from $4,000 to $25,000. It also helps uninsured or government-insured patients identify other support options, including the Pfizer Patient Assistance Program for those who cannot afford their medication.

Pfizer

The Pfizer Patient Assistance Program (PAP), part of Pfizer Oncology Together, offers financial assistance for IBRANCE medication costs. This includes co-pay assistance for commercially insured patients and free medication for eligible uninsured or government-insured patients through the PAP. Eligibility for free medication is based on financial need, and the program does not appear to cover travel expenses.

Pfizer

The Pfizer Patient Assistance Program offers financial support to eligible patients to help cover the cost of their prescribed Pfizer Oncology medicines. It assists individuals who cannot afford their medication, providing various options including co-pay assistance for commercially insured patients and support for those with government insurance plans. Patients are encouraged to apply if they need further financial help after exploring initial resources.

Pfizer

Pfizer

The Pfizer RxPathways program acts as a centralized resource listing various patient support programs offered by Pfizer, primarily focused on providing co-pay assistance, patient assistance, and reimbursement support for specific Pfizer medications and vaccines. The content provided does not indicate that Pfizer RxPathways itself, or any of the programs listed within it, offers financial assistance for patient travel expenses.

Pfizer

This page, part of Pfizer RxPathways, acts as a directory for various patient assistance programs primarily focused on financial help for specific Pfizer medications, including co-pay assistance and free medicine programs. No information regarding a patient travel assistance grant, or coverage for travel-related expenses like flights or accommodation, is present in the provided content.

Pfizer

The Pfizer RxPathways Patient Support Hub provides information on various patient assistance programs primarily focused on financial assistance, co-pay support, and reimbursement services for Pfizer medicines and vaccines. The content does not describe any programs that specifically offer travel assistance such as flights, hotel, or gas for patients.

Pfizer

The Pfizer RxPathways Support Hub serves as a directory for various Pfizer patient assistance programs. These programs primarily offer financial assistance for Pfizer medications, including co-pay support, savings cards, and free medicine for eligible patients based on financial hardship. There is no mention of travel assistance, such as flights, hotel, or gas, being covered by any of the listed programs.

Pfizer

Pfizer

Pfizer

Pfizer

This page lists various Pfizer patient support programs primarily offering co-pay assistance, reimbursement support, and financial aid for specific Pfizer medications. No information regarding travel assistance grants, such as coverage for flights, hotels, or gas, is provided on this page.

Pfizer

The Pfizer RxPathways Support Hub Programs offer a variety of patient support services, primarily focused on financial assistance, co-pay savings, and reimbursement support for specific Pfizer medicines. The information provided on this page does not indicate any offerings for travel assistance. Eligibility for the various medication support programs typically includes income requirements (ranging from 300% to 500% of the Federal Poverty Level for free medicine) and specific prescription criteria.

Pfizer

The provided page details various Pfizer patient assistance programs, primarily offering co-pay assistance, savings cards, and free medicine for specific Pfizer prescription drugs. There is no information found on this page regarding travel assistance, such as coverage for flights, hotel, or gas.

Pfizer

This page serves as a hub for various Pfizer and related patient support programs, predominantly offering co-pay assistance, reimbursement support, and free medicine for specific medications. The provided content does not include information about a patient travel assistance grant, its coverage, or eligibility requirements.

PAN Foundation

The PAN Foundation offers financial assistance through the Philadelphia chromosome negative myeloproliferative neoplasms Fund. This grant is currently open and covers transportation purchases for eligible patients. Applicants must verify their income to qualify for assistance.

The Assistance Fund

The Pompe Disease Financial Assistance Program by The Assistance Fund offers grants for out-of-pocket costs related to Pompe disease, including prescription drugs, health insurance premiums, therapy administration, and travel to treatment centers or specialists (ground/air transportation, meals, hotel). Eligible patients must be U.S. citizens or permanent residents, diagnosed with Pompe disease, prescribed an FDA-approved treatment, have prescription coverage, and meet financial eligibility criteria based on household income and size. The program is currently on a waitlist.

PAN Foundation

This grant, named 'Pompe disease medication copay assistance', is offered by the PAN Foundation and is currently open for applications. The available page content does not specify if this particular fund covers travel expenses; its name suggests a focus on medication copay assistance.

PAN Foundation

PrescriberPoint

This program provides financial assistance to eligible residents of the US and Puerto Rico who are prescribed Tarpeyo, Filspari, or Fabhalta for Immunoglobulin A Nephropathy (IgAN). It covers copays, coinsurance, deductibles, health insurance premiums, and incidental medical expenses, and requires patients to be commercially insured or have Medicare/Medicaid and meet income guidelines.

The Assistance Fund

The Primary Immunodeficiency Financial Assistance Program provides financial aid for out-of-pocket costs including prescription drug assistance (copays, deductibles, coinsurance), health insurance premiums, therapy administration, and travel expenses (ground transport, air travel, meals, hotel stay) to a treatment center. To qualify, patients must be U.S. citizens or permanent residents diagnosed with primary immunodeficiency, have a prescribed FDA-approved treatment with prescription coverage, and meet financial eligibility criteria based on household income and size. The program is currently accepting requests to join its enrollment waitlist.